Overview

Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients.

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
Applying nanotechnology in drug delivery systems improved the bioavailability and kinetic profile of drugs in biological systems
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine